GHRH analogue clinically proven to reduce visceral (deep belly) fat and improve body composition.
Tesamorelin is a stabilized GHRH analogue and one of the few growth-hormone peptides with full FDA approval. As Egrifta it is approved to reduce excess visceral (deep abdominal) fat in HIV-associated lipodystrophy.
It works by stimulating the pituitary to release your own growth hormone in a natural pattern, which preferentially mobilizes visceral fat — the metabolically dangerous fat around the organs — while also modestly improving lipids.
Its clinical pedigree makes it stand out: the visceral-fat reduction is documented in proper randomized trials, not just anecdote. It does raise IGF-1 and can nudge blood sugar, so monitoring matters.
Specifically reduces deep abdominal (visceral) fat.
FDA-approved for this; demonstrated in randomized controlled trials
Improves the fat-to-lean ratio via natural GH release.
Clinical-grade evidence in its approved population
Modest improvements in triglycerides and related markers follow the fat loss.
Documented in trials; monitor glucose and IGF-1
We rate every peptide honestly across four dimensions — and tell you what it's not.
Backed by human clinical data — one or more controlled human trials show a consistent effect.
Men specifically targeting stubborn visceral belly fat and metabolic risk
Inject at night on an empty stomach. Monitor IGF-1 and fasting glucose. The most evidence-backed GH peptide for visceral fat.
Women targeting visceral fat and body composition
Used by women for visceral fat with no direct hormonal interactions. Monitor blood sugar. Contraindicated in pregnancy and with active cancer.
Used by women for visceral fat reduction; avoid in pregnancy.
This section is always free and never locked.
Do not use with active malignancy.
Contraindicated in pregnancy.
Can raise IGF-1 and blood glucose — monitor periodically.
Inject at night on an empty stomach for the best GH response.
The effects most commonly reported with Tesamorelin, when they tend to show up, and how to manage them.
Rotate sites; usually mild redness.
Lower the dose if persistent; monitor IGF-1.
Individual responses vary. Stop and consult a clinician for severe, persistent, or unexpected reactions.
14 steps with photos, pro tips, and a dosing calculator.
Unlock Full Guide7 days free. Then $24/month.
████████ ████
████████ ████
████████ ████
Dosing info requires Core or Pro
Unlock DosingAlways free. Never locked.
A preview of the member outcomes dashboard. Real, anonymized Tesamorelin results populate here as the community logs data.
See aggregated results from real users — benefit ratings, common goals, side effect frequency, and more.
Unlock with Core or ProGet the complete step-by-step guide, personalized dosing, and daily tracking.
View Full GuidePepCompass provides educational information only. Nothing on this platform constitutes medical advice, diagnosis, or treatment. All content is for informational and research purposes only. Always consult a licensed healthcare provider before starting any peptide protocol. Individual results vary.